ReviewDrug design, development and therapy2023
Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment.
Ya-Li Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewDrug design, development and therapy2023
Ya-Li Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.